Phil Walls Quoted in Article for Work Comp Central
September 06, 2019
In response to ongoing efforts to fight the opioid crisis, drug companies are working to bring non-addictive opioid pain medication to market. With the FDA’s announcement to postpone the decision to approve a new type of this drug, loxicodegol, Work Comp Central Magazine reached out to myMatrixx...
Learn more